What is the evidence for the use of Low Molecular Weight Heparins for the prophylaxis of travel-related thrombosis?

This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism

Prescribing Outlook 2018

Please note that only people with an NHS login will be able to access these documents (see below for details). The Prescribing Outlook Series assists NHS…

NOACs and Antidepressants - What are the risks of using these together and how should these risks be managed?

This article considers the risk of interactions between NOACs and antidepressants. Non-vitamin K antagonist oral anticoagulants (NOACs) appear to have fewer clinically significant drug interactions…

Shortage of colestyramine powder for oral suspension (4g) (Questran and Questran Light)

Bristol-Myers Squibb are currently the only supplier of these products and they are facing manufacturing difficulties. Further supplies of Questran Light are expected in early…